PPP1R26: A Potential Drug Target and Biomarker for Protein Phosphatase 1

Target Name: PPP1R26

NCBI ID: G9858

PPP1R26

PPP1R26: A Potential Drug Target and Biomarker for Protein Phosphatase 1

Introduction

Protein phosphorylation is an important cell biological process and plays a key role in biological processes such as cell signal transduction, metabolic regulation, and cell cycle regulation. Among many phosphorylases, PP1 and PP26 of the protein phosphatase (PP) family play important roles in metabolic regulation. The phosphorylation modification of PP1 and PP26 has important biological significance in tumorigenesis, apoptosis, neurodegenerative diseases, etc. At the same time, studying the roles of PP1 and PP26 in biological processes also provides new ideas for drug development. This article will focus on PP1R26, a potential drug target and biomarker.

Structure and function of PP1R26

PP1R26 is a protein belonging to the PP family, and its encoding gene is NM_001123.1. PP1R26 has rich expression patterns in cells, including different organelles such as cytoplasm, nucleus and cytoplasmic membrane. In the nucleus, PP1R26 is mainly located in the chromatin domain and is responsible for playing a role in biological processes such as DNA replication, transcription and gene expression.

Phosphorylation site of PP1R26

PP1R26 has multiple phosphorylation sites, the most significant of which is the N-terminal phosphorylation site. The N-terminal phosphorylation site is the main target of PP1R26 phosphorylation modification, and phosphorylation modification plays a key role in biological processes. Through phosphorylation modification, PP1R26 can regulate chromatin structure and affect biological processes such as gene expression and cell cycle regulation.

Pharmacological significance of PP1R26

PP1R26 plays an important role in biological processes and is therefore considered a potential drug target. By inhibiting the phosphorylation modification of PP1R26, the incidence of diseases such as tumorigenesis, apoptosis, and neurodegenerative diseases can be reduced. In addition, studying the phosphorylation modification of PP1R26 can also provide new targets for drug development. Currently, a variety of drugs that inhibit PP1R26 phosphorylation modification have been widely used in clinical research, such as anti-tumor drugs, antidepressants, and antipsychotic drugs.

Biomarkers for PP1R26

PP1R26 has important biological significance in biological processes and has therefore been studied as a biomarker. Phosphorylation modification of PP1R26 has important biological significance in tumorigenesis, apoptosis and neurodegenerative diseases. Therefore, detecting the phosphorylation modification level of PP1R26 can indirectly reflect the development degree and therapeutic effect of these diseases. At present, many studies have explored the biomarker role of PP1R26 in tumors, neurodegenerative diseases, etc., providing new ideas for the diagnosis and treatment of these diseases.

in conclusion

PP1R26 is a potential drug target and biomarker. By studying the phosphorylation modification of PP1R26, its important role in biological processes can be revealed and provide new ideas for drug development. At the same time, studying the phosphorylation modification level of PP1R26 can provide new biomarkers for the diagnosis and treatment of tumors, neurodegenerative diseases and other diseases. In the future, with further research, PP1R26 is expected to become a protein with important biological significance and clinical application prospects.

Protein Name: Protein Phosphatase 1 Regulatory Subunit 26

Functions: Inhibits phosphatase activity of protein phosphatase 1 (PP1) complexes. May positively regulate cell proliferation

The "PPP1R26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP1R26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets